Citigroup’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.07M Sell
76,315
-117,689
-61% -$1.65M ﹤0.01% 2488
2025
Q1
$2.64M Buy
194,004
+27,298
+16% +$371K ﹤0.01% 1867
2024
Q4
$3.4M Buy
166,706
+71,992
+76% +$1.47M ﹤0.01% 1736
2024
Q3
$2.76M Buy
94,714
+50,163
+113% +$1.46M ﹤0.01% 1802
2024
Q2
$1.03M Sell
44,551
-337,865
-88% -$7.85M ﹤0.01% 2245
2024
Q1
$7.85M Buy
382,416
+241,140
+171% +$4.95M 0.01% 1014
2023
Q4
$3.03M Buy
141,276
+2,967
+2% +$63.7K ﹤0.01% 1386
2023
Q3
$2.85M Buy
138,309
+30,282
+28% +$625K ﹤0.01% 1294
2023
Q2
$3.19M Sell
108,027
-100,313
-48% -$2.96M ﹤0.01% 1365
2023
Q1
$4.8M Buy
208,340
+80,220
+63% +$1.85M ﹤0.01% 1134
2022
Q4
$3.56M Sell
128,120
-64,522
-33% -$1.79M ﹤0.01% 1215
2022
Q3
$5.91M Buy
192,642
+80,828
+72% +$2.48M ﹤0.01% 1044
2022
Q2
$3.29M Buy
111,814
+76,430
+216% +$2.25M ﹤0.01% 1296
2022
Q1
$1.14M Sell
35,384
-84,997
-71% -$2.73M ﹤0.01% 2227
2021
Q4
$5.37M Buy
120,381
+11,356
+10% +$506K ﹤0.01% 1241
2021
Q3
$5.5M Buy
109,025
+43,778
+67% +$2.21M ﹤0.01% 1249
2021
Q2
$5.12M Sell
65,247
-4,527
-6% -$355K ﹤0.01% 1404
2021
Q1
$3.98M Buy
69,774
+52,179
+297% +$2.98M ﹤0.01% 1483
2020
Q4
$1.47M Buy
17,595
+10,651
+153% +$892K ﹤0.01% 1896
2020
Q3
$249K Sell
6,944
-42,920
-86% -$1.54M ﹤0.01% 2666
2020
Q2
$1.21M Buy
49,864
+12,000
+32% +$290K ﹤0.01% 1967
2020
Q1
$663K Buy
37,864
+20,342
+116% +$356K ﹤0.01% 2106
2019
Q4
$305K Sell
17,522
-60,995
-78% -$1.06M ﹤0.01% 2915
2019
Q3
$1.2M Buy
78,517
+14,034
+22% +$215K ﹤0.01% 1981
2019
Q2
$1.34M Buy
64,483
+52,480
+437% +$1.09M ﹤0.01% 1921
2019
Q1
$279K Sell
12,003
-77,311
-87% -$1.8M ﹤0.01% 2904
2018
Q4
$1.85M Buy
89,314
+76,458
+595% +$1.58M ﹤0.01% 1588
2018
Q3
$279K Buy
12,856
+10,429
+430% +$226K ﹤0.01% 2923
2018
Q2
$37K Buy
2,427
+132
+6% +$2.01K ﹤0.01% 4046
2018
Q1
$45K Buy
+2,295
New +$45K ﹤0.01% 3810